[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceutical Cannabis Market, Global Outlook and Forecast 2022-2028

July 2024 | 79 pages | ID: P928DBE3EA7EEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Pharmaceutical Cannabis in global, including the following market information:

Global Pharmaceutical Cannabis Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Pharmaceutical Cannabis Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Pharmaceutical Cannabis companies in 2021 (%)

The global Pharmaceutical Cannabis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

THC-dominant Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pharmaceutical Cannabis include Canopy Growth Corporation, GW Pharmaceuticals, plc, Aurora Cannabis, Inc., Aphria, Inc., MedReleaf Corporation, Insys Therapeutics, Inc., CanniMed Therapeutics, Inc., Cara Therapeutics, Inc. and United Cannabis Corporation. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceutical Cannabis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pharmaceutical Cannabis Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pharmaceutical Cannabis Market Segment Percentages, by Type, 2021 (%)
  • THC-dominant
  • CBD-dominant
  • Balanced THC & CBD
Global Pharmaceutical Cannabis Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pharmaceutical Cannabis Market Segment Percentages, by Application, 2021 (%)
  • Cancer
  • Arthritis
  • Migraine
  • Epilepsy
  • Others
Global Pharmaceutical Cannabis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pharmaceutical Cannabis Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pharmaceutical Cannabis revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Pharmaceutical Cannabis revenues share in global market, 2021 (%)

Key companies Pharmaceutical Cannabis sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Pharmaceutical Cannabis sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Canopy Growth Corporation
  • GW Pharmaceuticals, plc
  • Aurora Cannabis, Inc.
  • Aphria, Inc.
  • MedReleaf Corporation
  • Insys Therapeutics, Inc.
  • CanniMed Therapeutics, Inc.
  • Cara Therapeutics, Inc.
  • United Cannabis Corporation
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pharmaceutical Cannabis Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Pharmaceutical Cannabis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PHARMACEUTICAL CANNABIS OVERALL MARKET SIZE

2.1 Global Pharmaceutical Cannabis Market Size: 2021 VS 2028
2.2 Global Pharmaceutical Cannabis Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Pharmaceutical Cannabis Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Pharmaceutical Cannabis Players in Global Market
3.2 Top Global Pharmaceutical Cannabis Companies Ranked by Revenue
3.3 Global Pharmaceutical Cannabis Revenue by Companies
3.4 Global Pharmaceutical Cannabis Sales by Companies
3.5 Global Pharmaceutical Cannabis Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Pharmaceutical Cannabis Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Pharmaceutical Cannabis Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pharmaceutical Cannabis Players in Global Market
  3.8.1 List of Global Tier 1 Pharmaceutical Cannabis Companies
  3.8.2 List of Global Tier 2 and Tier 3 Pharmaceutical Cannabis Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Pharmaceutical Cannabis Market Size Markets, 2021 & 2028
  4.1.2 THC-dominant
  4.1.3 CBD-dominant
  4.1.4 Balanced THC & CBD
4.2 By Type - Global Pharmaceutical Cannabis Revenue & Forecasts
  4.2.1 By Type - Global Pharmaceutical Cannabis Revenue, 2017-2022
  4.2.2 By Type - Global Pharmaceutical Cannabis Revenue, 2023-2028
  4.2.3 By Type - Global Pharmaceutical Cannabis Revenue Market Share, 2017-2028
4.3 By Type - Global Pharmaceutical Cannabis Sales & Forecasts
  4.3.1 By Type - Global Pharmaceutical Cannabis Sales, 2017-2022
  4.3.2 By Type - Global Pharmaceutical Cannabis Sales, 2023-2028
  4.3.3 By Type - Global Pharmaceutical Cannabis Sales Market Share, 2017-2028
4.4 By Type - Global Pharmaceutical Cannabis Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pharmaceutical Cannabis Market Size, 2021 & 2028
  5.1.2 Cancer
  5.1.3 Arthritis
  5.1.4 Migraine
  5.1.5 Epilepsy
  5.1.6 Others
5.2 By Application - Global Pharmaceutical Cannabis Revenue & Forecasts
  5.2.1 By Application - Global Pharmaceutical Cannabis Revenue, 2017-2022
  5.2.2 By Application - Global Pharmaceutical Cannabis Revenue, 2023-2028
  5.2.3 By Application - Global Pharmaceutical Cannabis Revenue Market Share, 2017-2028
5.3 By Application - Global Pharmaceutical Cannabis Sales & Forecasts
  5.3.1 By Application - Global Pharmaceutical Cannabis Sales, 2017-2022
  5.3.2 By Application - Global Pharmaceutical Cannabis Sales, 2023-2028
  5.3.3 By Application - Global Pharmaceutical Cannabis Sales Market Share, 2017-2028
5.4 By Application - Global Pharmaceutical Cannabis Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Pharmaceutical Cannabis Market Size, 2021 & 2028
6.2 By Region - Global Pharmaceutical Cannabis Revenue & Forecasts
  6.2.1 By Region - Global Pharmaceutical Cannabis Revenue, 2017-2022
  6.2.2 By Region - Global Pharmaceutical Cannabis Revenue, 2023-2028
  6.2.3 By Region - Global Pharmaceutical Cannabis Revenue Market Share, 2017-2028
6.3 By Region - Global Pharmaceutical Cannabis Sales & Forecasts
  6.3.1 By Region - Global Pharmaceutical Cannabis Sales, 2017-2022
  6.3.2 By Region - Global Pharmaceutical Cannabis Sales, 2023-2028
  6.3.3 By Region - Global Pharmaceutical Cannabis Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Pharmaceutical Cannabis Revenue, 2017-2028
  6.4.2 By Country - North America Pharmaceutical Cannabis Sales, 2017-2028
  6.4.3 US Pharmaceutical Cannabis Market Size, 2017-2028
  6.4.4 Canada Pharmaceutical Cannabis Market Size, 2017-2028
  6.4.5 Mexico Pharmaceutical Cannabis Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Pharmaceutical Cannabis Revenue, 2017-2028
  6.5.2 By Country - Europe Pharmaceutical Cannabis Sales, 2017-2028
  6.5.3 Germany Pharmaceutical Cannabis Market Size, 2017-2028
  6.5.4 France Pharmaceutical Cannabis Market Size, 2017-2028
  6.5.5 U.K. Pharmaceutical Cannabis Market Size, 2017-2028
  6.5.6 Italy Pharmaceutical Cannabis Market Size, 2017-2028
  6.5.7 Russia Pharmaceutical Cannabis Market Size, 2017-2028
  6.5.8 Nordic Countries Pharmaceutical Cannabis Market Size, 2017-2028
  6.5.9 Benelux Pharmaceutical Cannabis Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Pharmaceutical Cannabis Revenue, 2017-2028
  6.6.2 By Region - Asia Pharmaceutical Cannabis Sales, 2017-2028
  6.6.3 China Pharmaceutical Cannabis Market Size, 2017-2028
  6.6.4 Japan Pharmaceutical Cannabis Market Size, 2017-2028
  6.6.5 South Korea Pharmaceutical Cannabis Market Size, 2017-2028
  6.6.6 Southeast Asia Pharmaceutical Cannabis Market Size, 2017-2028
  6.6.7 India Pharmaceutical Cannabis Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Pharmaceutical Cannabis Revenue, 2017-2028
  6.7.2 By Country - South America Pharmaceutical Cannabis Sales, 2017-2028
  6.7.3 Brazil Pharmaceutical Cannabis Market Size, 2017-2028
  6.7.4 Argentina Pharmaceutical Cannabis Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Pharmaceutical Cannabis Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Pharmaceutical Cannabis Sales, 2017-2028
  6.8.3 Turkey Pharmaceutical Cannabis Market Size, 2017-2028
  6.8.4 Israel Pharmaceutical Cannabis Market Size, 2017-2028
  6.8.5 Saudi Arabia Pharmaceutical Cannabis Market Size, 2017-2028
  6.8.6 UAE Pharmaceutical Cannabis Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Canopy Growth Corporation
  7.1.1 Canopy Growth Corporation Corporate Summary
  7.1.2 Canopy Growth Corporation Business Overview
  7.1.3 Canopy Growth Corporation Pharmaceutical Cannabis Major Product Offerings
  7.1.4 Canopy Growth Corporation Pharmaceutical Cannabis Sales and Revenue in Global (2017-2022)
  7.1.5 Canopy Growth Corporation Key News
7.2 GW Pharmaceuticals, plc
  7.2.1 GW Pharmaceuticals, plc Corporate Summary
  7.2.2 GW Pharmaceuticals, plc Business Overview
  7.2.3 GW Pharmaceuticals, plc Pharmaceutical Cannabis Major Product Offerings
  7.2.4 GW Pharmaceuticals, plc Pharmaceutical Cannabis Sales and Revenue in Global (2017-2022)
  7.2.5 GW Pharmaceuticals, plc Key News
7.3 Aurora Cannabis, Inc.
  7.3.1 Aurora Cannabis, Inc. Corporate Summary
  7.3.2 Aurora Cannabis, Inc. Business Overview
  7.3.3 Aurora Cannabis, Inc. Pharmaceutical Cannabis Major Product Offerings
  7.3.4 Aurora Cannabis, Inc. Pharmaceutical Cannabis Sales and Revenue in Global (2017-2022)
  7.3.5 Aurora Cannabis, Inc. Key News
7.4 Aphria, Inc.
  7.4.1 Aphria, Inc. Corporate Summary
  7.4.2 Aphria, Inc. Business Overview
  7.4.3 Aphria, Inc. Pharmaceutical Cannabis Major Product Offerings
  7.4.4 Aphria, Inc. Pharmaceutical Cannabis Sales and Revenue in Global (2017-2022)
  7.4.5 Aphria, Inc. Key News
7.5 MedReleaf Corporation
  7.5.1 MedReleaf Corporation Corporate Summary
  7.5.2 MedReleaf Corporation Business Overview
  7.5.3 MedReleaf Corporation Pharmaceutical Cannabis Major Product Offerings
  7.5.4 MedReleaf Corporation Pharmaceutical Cannabis Sales and Revenue in Global (2017-2022)
  7.5.5 MedReleaf Corporation Key News
7.6 Insys Therapeutics, Inc.
  7.6.1 Insys Therapeutics, Inc. Corporate Summary
  7.6.2 Insys Therapeutics, Inc. Business Overview
  7.6.3 Insys Therapeutics, Inc. Pharmaceutical Cannabis Major Product Offerings
  7.6.4 Insys Therapeutics, Inc. Pharmaceutical Cannabis Sales and Revenue in Global (2017-2022)
  7.6.5 Insys Therapeutics, Inc. Key News
7.7 CanniMed Therapeutics, Inc.
  7.7.1 CanniMed Therapeutics, Inc. Corporate Summary
  7.7.2 CanniMed Therapeutics, Inc. Business Overview
  7.7.3 CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Major Product Offerings
  7.7.4 CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Sales and Revenue in Global (2017-2022)
  7.7.5 CanniMed Therapeutics, Inc. Key News
7.8 Cara Therapeutics, Inc.
  7.8.1 Cara Therapeutics, Inc. Corporate Summary
  7.8.2 Cara Therapeutics, Inc. Business Overview
  7.8.3 Cara Therapeutics, Inc. Pharmaceutical Cannabis Major Product Offerings
  7.8.4 Cara Therapeutics, Inc. Pharmaceutical Cannabis Sales and Revenue in Global (2017-2022)
  7.8.5 Cara Therapeutics, Inc. Key News
7.9 United Cannabis Corporation
  7.9.1 United Cannabis Corporation Corporate Summary
  7.9.2 United Cannabis Corporation Business Overview
  7.9.3 United Cannabis Corporation Pharmaceutical Cannabis Major Product Offerings
  7.9.4 United Cannabis Corporation Pharmaceutical Cannabis Sales and Revenue in Global (2017-2022)
  7.9.5 United Cannabis Corporation Key News

8 GLOBAL PHARMACEUTICAL CANNABIS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Pharmaceutical Cannabis Production Capacity, 2017-2028
8.2 Pharmaceutical Cannabis Production Capacity of Key Manufacturers in Global Market
8.3 Global Pharmaceutical Cannabis Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 PHARMACEUTICAL CANNABIS SUPPLY CHAIN ANALYSIS

10.1 Pharmaceutical Cannabis Industry Value Chain
10.2 Pharmaceutical Cannabis Upstream Market
10.3 Pharmaceutical Cannabis Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Pharmaceutical Cannabis Distributors and Sales Agents in Global

11 CONCLUSION


12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of Pharmaceutical Cannabis in Global Market
Table 2. Top Pharmaceutical Cannabis Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Pharmaceutical Cannabis Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Pharmaceutical Cannabis Revenue Share by Companies, 2017-2022
Table 5. Global Pharmaceutical Cannabis Sales by Companies, (K Units), 2017-2022
Table 6. Global Pharmaceutical Cannabis Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Pharmaceutical Cannabis Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Pharmaceutical Cannabis Product Type
Table 9. List of Global Tier 1 Pharmaceutical Cannabis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmaceutical Cannabis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pharmaceutical Cannabis Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Pharmaceutical Cannabis Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Pharmaceutical Cannabis Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Pharmaceutical Cannabis Sales (K Units), 2017-2022
Table 15. By Type - Global Pharmaceutical Cannabis Sales (K Units), 2023-2028
Table 16. By Application – Global Pharmaceutical Cannabis Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Pharmaceutical Cannabis Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Pharmaceutical Cannabis Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Pharmaceutical Cannabis Sales (K Units), 2017-2022
Table 20. By Application - Global Pharmaceutical Cannabis Sales (K Units), 2023-2028
Table 21. By Region – Global Pharmaceutical Cannabis Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Pharmaceutical Cannabis Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Pharmaceutical Cannabis Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Pharmaceutical Cannabis Sales (K Units), 2017-2022
Table 25. By Region - Global Pharmaceutical Cannabis Sales (K Units), 2023-2028
Table 26. By Country - North America Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Pharmaceutical Cannabis Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Pharmaceutical Cannabis Sales, (K Units), 2017-2022
Table 29. By Country - North America Pharmaceutical Cannabis Sales, (K Units), 2023-2028
Table 30. By Country - Europe Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Pharmaceutical Cannabis Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Pharmaceutical Cannabis Sales, (K Units), 2017-2022
Table 33. By Country - Europe Pharmaceutical Cannabis Sales, (K Units), 2023-2028
Table 34. By Region - Asia Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Pharmaceutical Cannabis Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Pharmaceutical Cannabis Sales, (K Units), 2017-2022
Table 37. By Region - Asia Pharmaceutical Cannabis Sales, (K Units), 2023-2028
Table 38. By Country - South America Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Pharmaceutical Cannabis Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Pharmaceutical Cannabis Sales, (K Units), 2017-2022
Table 41. By Country - South America Pharmaceutical Cannabis Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Pharmaceutical Cannabis Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Pharmaceutical Cannabis Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Pharmaceutical Cannabis Sales, (K Units), 2023-2028
Table 46. Canopy Growth Corporation Corporate Summary
Table 47. Canopy Growth Corporation Pharmaceutical Cannabis Product Offerings
Table 48. Canopy Growth Corporation Pharmaceutical Cannabis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. GW Pharmaceuticals, plc Corporate Summary
Table 50. GW Pharmaceuticals, plc Pharmaceutical Cannabis Product Offerings
Table 51. GW Pharmaceuticals, plc Pharmaceutical Cannabis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Aurora Cannabis, Inc. Corporate Summary
Table 53. Aurora Cannabis, Inc. Pharmaceutical Cannabis Product Offerings
Table 54. Aurora Cannabis, Inc. Pharmaceutical Cannabis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Aphria, Inc. Corporate Summary
Table 56. Aphria, Inc. Pharmaceutical Cannabis Product Offerings
Table 57. Aphria, Inc. Pharmaceutical Cannabis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. MedReleaf Corporation Corporate Summary
Table 59. MedReleaf Corporation Pharmaceutical Cannabis Product Offerings
Table 60. MedReleaf Corporation Pharmaceutical Cannabis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Insys Therapeutics, Inc. Corporate Summary
Table 62. Insys Therapeutics, Inc. Pharmaceutical Cannabis Product Offerings
Table 63. Insys Therapeutics, Inc. Pharmaceutical Cannabis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. CanniMed Therapeutics, Inc. Corporate Summary
Table 65. CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Product Offerings
Table 66. CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Cara Therapeutics, Inc. Corporate Summary
Table 68. Cara Therapeutics, Inc. Pharmaceutical Cannabis Product Offerings
Table 69. Cara Therapeutics, Inc. Pharmaceutical Cannabis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. United Cannabis Corporation Corporate Summary
Table 71. United Cannabis Corporation Pharmaceutical Cannabis Product Offerings
Table 72. United Cannabis Corporation Pharmaceutical Cannabis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Pharmaceutical Cannabis Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 74. Global Pharmaceutical Cannabis Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Pharmaceutical Cannabis Production by Region, 2017-2022 (K Units)
Table 76. Global Pharmaceutical Cannabis Production by Region, 2023-2028 (K Units)
Table 77. Pharmaceutical Cannabis Market Opportunities & Trends in Global Market
Table 78. Pharmaceutical Cannabis Market Drivers in Global Market
Table 79. Pharmaceutical Cannabis Market Restraints in Global Market
Table 80. Pharmaceutical Cannabis Raw Materials
Table 81. Pharmaceutical Cannabis Raw Materials Suppliers in Global Market
Table 82. Typical Pharmaceutical Cannabis Downstream
Table 83. Pharmaceutical Cannabis Downstream Clients in Global Market
Table 84. Pharmaceutical Cannabis Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Pharmaceutical Cannabis Segment by Type
Figure 2. Pharmaceutical Cannabis Segment by Application
Figure 3. Global Pharmaceutical Cannabis Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pharmaceutical Cannabis Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pharmaceutical Cannabis Revenue, 2017-2028 (US$, Mn)
Figure 7. Pharmaceutical Cannabis Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pharmaceutical Cannabis Revenue in 2021
Figure 9. By Type - Global Pharmaceutical Cannabis Sales Market Share, 2017-2028
Figure 10. By Type - Global Pharmaceutical Cannabis Revenue Market Share, 2017-2028
Figure 11. By Type - Global Pharmaceutical Cannabis Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Pharmaceutical Cannabis Sales Market Share, 2017-2028
Figure 13. By Application - Global Pharmaceutical Cannabis Revenue Market Share, 2017-2028
Figure 14. By Application - Global Pharmaceutical Cannabis Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Pharmaceutical Cannabis Sales Market Share, 2017-2028
Figure 16. By Region - Global Pharmaceutical Cannabis Revenue Market Share, 2017-2028
Figure 17. By Country - North America Pharmaceutical Cannabis Revenue Market Share, 2017-2028
Figure 18. By Country - North America Pharmaceutical Cannabis Sales Market Share, 2017-2028
Figure 19. US Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Pharmaceutical Cannabis Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Pharmaceutical Cannabis Sales Market Share, 2017-2028
Figure 24. Germany Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 25. France Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Pharmaceutical Cannabis Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Pharmaceutical Cannabis Sales Market Share, 2017-2028
Figure 33. China Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 37. India Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Pharmaceutical Cannabis Revenue Market Share, 2017-2028
Figure 39. By Country - South America Pharmaceutical Cannabis Sales Market Share, 2017-2028
Figure 40. Brazil Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Pharmaceutical Cannabis Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Pharmaceutical Cannabis Sales Market Share, 2017-2028
Figure 44. Turkey Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Pharmaceutical Cannabis Revenue, (US$, Mn), 2017-2028
Figure 48. Global Pharmaceutical Cannabis Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Pharmaceutical Cannabis by Region, 2021 VS 2028
Figure 50. Pharmaceutical Cannabis Industry Value Chain
Figure 51. Marketing Channels


More Publications